Status:
COMPLETED
Excretion of Radiolabelled AZD0837
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
This is an explorative study and the scientific question to be investigated in this study is if AZD0837 and/or its metabolites AR-H069927XX and AR-H067637XX and other unknown metabolites are excreted ...
Eligibility Criteria
Inclusion
- body mass index (BMI) between 19 to 30 kg/m2 and body weight between 50 to 100 kg inclusive
Exclusion
- Significant illness, trauma or surgical procedures.
- Clinically significant laboratory abnormalities.
- Clinically significant medical history.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00812643
Start Date
January 1 2009
End Date
February 1 2009
Last Update
March 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Uppsala, Sweden